<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-3NK3GOCW</identifier><date>2026</date><creator>Ivanuš, Urška</creator><creator>Jarm, Katja</creator><creator>Kofol-Bric, Tatjana</creator><creator>Kovše, Katja</creator><creator>Novak-Mlakar, Dominika</creator><relation>documents/doc/3/URN_NBN_SI_doc-3NK3GOCW_001.pdf</relation><relation>documents/doc/3/URN_NBN_SI_doc-3NK3GOCW_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 14-22</format><identifier identifier_type="COBISSID_HOST">279865091</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-3NK3GOCW</identifier><language>slv</language><publisher publisher_location="Ljubljana">Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><source>37. onkološki vikend</source><rights>InC</rights><subject language_type_id="slv">epidemiologija</subject><subject language_type_id="slv">obvladovanje raka</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">presejalni programi</subject><title>Presejalni programi za raka</title><title>pričakovanja in dejanski učinki programov Svit, Dora in Zora po desetletju ter pogled proti novim presejalnim programom</title></Record>